NEW YORK (GenomeWeb) – A group of experts has recommended that newly diagnosed colorectal cancer patients should receive genetic tests to identify which ones may have Lynch syndrome, the American Gastroenterological Association said today.

The US Multi-Society Task Force on Colorectal Cancer, a group of specialists representing several professional organizations, recommends all new colorectal cancer patients should be tested for evidence of mismatch repair (MMR) deficiency.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.